Mr. William J. Garner - 24 Jan 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Reporting relationship: Director
Issuer ticker: INM
Reported as of: 24 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jan 2022, 15:19:27 UTC
Prior SEC filing: 30 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Bruce Colwill, attorney-in-fact for Mr. William J. Garner

Key filing fact

Mr. William J. Garner filed Form 4 for InMed Pharmaceuticals Inc. (INM) on 24 Jan 2022.

Key facts

This page summarizes Mr. William J. Garner's Form 4 filing for InMed Pharmaceuticals Inc. (INM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jan 2022, 15:19.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INM transaction Derivative

Expiration (or cancellation) of long derivative position with value received

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Converted from the Canadian dollar exercise price of C$4.29 using an exchange rate of C$1.2554 = $US1.00